26
20
Brain Tumor Reports

Volume 12 Supplement 2
February 2012

Home > Publications > Brain Tumor Reports > Volume 12, Year 2012 > Supplement 2, February°


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS





BRAIN TUMORS



Sun T, Warrington NM, Rubin JB.
Why Does Jack and not Jill Break His Crown: Sex Disparity in Brain Tumors.
Biol Sex Differ. 2012 Jan 25;3(1):3. [Epub ahead of print]




Warrington JP, Csiszar A, Mitschelen M, Lee YW, Sonntag WE.
Whole brain radiation-induced impairments in learning and memory are time-sensitive and reversible by systemic hypoxia.
PLoS One. 2012;7(1):e30444. Epub 2012 Jan 18.




Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G.
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.
J Neurooncol. 2012 Feb 18. [Epub ahead of print]
Abstract | Related articles




Swartling FJ.
Myc proteins in brain tumor development and maintenance.
Ups J Med Sci. 2012 Feb 21. [Epub ahead of print]
Abstract | Full text | Related articles




Talacchi A, d'Avella D, Denaro L, Santini B, Meneghelli P, Savazzi S, Gerosa M.
Cognitive outcome as part and parcel of clinical outcome in brain tumor surgery.
J Neurooncol. 2012 Feb 18. [Epub ahead of print]
Abstract | Related articles





GLIOBLASTOMA



Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Schmainda KM.
Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume.
Magn Reson Med. 2011 Dec 28. doi: 10.1002/mrm.23315. [Epub ahead of print]




Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, O'Neill B, Faul C.
A clinical review of treatment outcomes in glioblastoma multiforme - the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
Br J Radiol. 2012 Jan 3. [Epub ahead of print]




Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG.
Neoplastic cells are a rare component in human glioblastoma microvasculature.
Oncotarget. 2012 Jan 30;. [Epub ahead of print]




Timotheadou E.
New agents targeting angiogenesis in glioblastoma.
Chemother Res Pract. 2011;2011:878912.




Taylor TE, Furnari FB, Cavenee WK.
Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance.
Curr Cancer Drug Targets. 2012 Jan 16. [Epub ahead of print]




Vauleon E, Mesbah H, Gedouin D, Lecouillard I, Louvel G, Hamlat A, Riffaud L, Carsin B, Quillien V, Audrain O, Lesimple T.
Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab.
Bull Cancer. 2012 Jan 17. [Epub ahead of print]





GLIOMAS



Martin M.
Research Reinforces Potential Allergies-Glioma Connection.
J Natl Cancer Inst. 2012 Feb 20. [Epub ahead of print]
Abstract | Related articles




HIGH-GRADE GLIOMAS


Sands SA, Zhou T, O'Neil SH, Patel SK, Allen J, McGuire Cullen P, Kaleita TA, Noll R, Sklar C, Finlay JL.
Long-Term Follow-Up of Children Treated for High-Grade Gliomas: Children's Oncology Group L991 Final Study Report.
J Clin Oncol. 2012 Feb 21. [Epub ahead of print]
Abstract | Related articles